TY - JOUR
T1 - X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis
AU - UK-PBC Consortium
AU - Japan PBC-GWAS Consortium
AU - Canadian-US PBC Consortium
AU - Italian PBC Genetics Study Group
AU - Asselta, Rosanna
AU - Paraboschi, Elvezia M.
AU - Gerussi, Alessio
AU - Cordell, Heather J.
AU - Mells, George F.
AU - Sandford, Richard N.
AU - Jones, David E.
AU - Nakamura, Minoru
AU - Ueno, Kazuko
AU - Hitomi, Yuki
AU - Kawashima, Minae
AU - Nishida, Nao
AU - Tokunaga, Katsushi
AU - Nagasaki, Masao
AU - Tanaka, Atsushi
AU - Tang, Ruqi
AU - Li, Zhiqiang
AU - Shi, Yongyong
AU - Liu, Xiangdong
AU - Xiong, Ma
AU - Hirschfield, Gideon
AU - Siminovitch, Katherine A.
AU - Walker, Erin
AU - Xie, Gang
AU - Mason, Andy
AU - Myers, Robert
AU - Peltekian, Kevork
AU - Ghent, Cameron
AU - Atkinson, Elizabeth
AU - Juran, Bruce
AU - Lazaridis, Kostas
AU - Lu, Yue
AU - Gu, Xiangjun
AU - Jing, Kaiyan
AU - Amos, Chris
AU - Affronti, Andrea
AU - Brunetto, Maurizia
AU - Coco, Barbara
AU - Spinzi, Giancarlo
AU - Elia, Gianfranco
AU - Ferrari, Carlo
AU - Lleo, Ana
AU - Muratori, Luigi
AU - Muratori, Paolo
AU - Portincasa, Piero
AU - Colli, Agostino
AU - Bruno, Savino
AU - Colloredo, Guido
AU - Azzaroli, Francesco
AU - Takaki, Akinobu
N1 - Funding Information:
Funding This study was partly supported by Italian Ministry of Health grants (PE-2016-02363915 and GR-2018-12367794), National Institutes of Health grant R01DK091823, and National Natural Science Foundation of China grants (81830016 and 81620108002 to XM). The authors thank Associazione Malattie Autoimmuni del Fegato (AMAF) Monza Organizzazione non lucrativa di utilit? sociale (ONLUS) and Associazione Italiana Ricerca Colangite Sclerosante (AIRCS) for the unrestricted research funding. This work was also supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (15K19314 to 17K15924 to Yuki Hitomi; 15K06908 to Minae Kawashima; 15K19357 and 17K09449 to Yoshihiro Aiba; and 23591006, 26293181, and 17H04169 to Minoru Nakamura), a Grant-in-Aid for Clinical Research from the National Hospital Organization (to Minoru Nakamura), a grant from the Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan to Minoru Nakamura, a grant from the Takeda Foundation (to Yuki Hitomi), and grants from the Japan Agency for Medical Research and Development (JP19km0405205 and JP19km0405501h0001 to Katsushi Tokunaga and Masao Nagasaki). Marco Carbone, Alessio Gerussi, and Pietro Invernizzi are members of the European Reference Network on Hepatological Diseases.
Funding Information:
Funding This study was partly supported by Italian Ministry of Health grants (PE-2016-02363915 and GR-2018-12367794), National Institutes of Health grant R01DK091823, and National Natural Science Foundation of China grants (81830016 and 81620108002 to XM). The authors thank Associazione Malattie Autoimmuni del Fegato (AMAF) Monza Organizzazione non lucrativa di utilità sociale (ONLUS) and Associazione Italiana Ricerca Colangite Sclerosante (AIRCS) for the unrestricted research funding. This work was also supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (15K19314 to 17K15924 to Yuki Hitomi; 15K06908 to Minae Kawashima; 15K19357 and 17K09449 to Yoshihiro Aiba; and 23591006, 26293181, and 17H04169 to Minoru Nakamura), a Grant-in-Aid for Clinical Research from the National Hospital Organization (to Minoru Nakamura), a grant from the Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan to Minoru Nakamura, a grant from the Takeda Foundation (to Yuki Hitomi), and grants from the Japan Agency for Medical Research and Development (JP19km0405205 and JP19km0405501h0001 to Katsushi Tokunaga and Masao Nagasaki). Marco Carbone, Alessio Gerussi, and Pietro Invernizzi are members of the European Reference Network on Hepatological Diseases.
Publisher Copyright:
© 2021 AGA Institute
PY - 2021/6
Y1 - 2021/6
N2 - Background & Aims: Genome-wide association studies in primary biliary cholangitis (PBC) have failed to find X chromosome (chrX) variants associated with the disease. Here, we specifically explore the chrX contribution to PBC, a sexually dimorphic complex autoimmune disease. Methods: We performed a chrX-wide association study, including genotype data from 5 genome-wide association studies (from Italy, United Kingdom, Canada, China, and Japan; 5244 case patients and 11,875 control individuals). Results: Single-marker association analyses found approximately 100 loci displaying P < 5 × 10–4, with the most significant being a signal within the OTUD5 gene (rs3027490; P = 4.80 × 10–6; odds ratio [OR], 1.39; 95% confidence interval [CI], 1.028–1.88; Japanese cohort). Although the transethnic meta-analysis evidenced only a suggestive signal (rs2239452, mapping within the PIM2 gene; OR, 1.17; 95% CI, 1.09–1.26; P = 9.93 × 10–8), the population-specific meta-analysis showed a genome-wide significant locus in East Asian individuals pointing to the same region (rs7059064, mapping within the GRIPAP1 gene; P = 6.2 × 10–9; OR, 1.33; 95% CI, 1.21–1.46). Indeed, rs7059064 tags a unique linkage disequilibrium block including 7 genes: TIMM17B, PQBP1, PIM2, SLC35A2, OTUD5, KCND1, and GRIPAP1, as well as a superenhancer (GH0XJ048933 within OTUD5) targeting all these genes. GH0XJ048933 is also predicted to target FOXP3, the main T-regulatory cell lineage specification factor. Consistently, OTUD5 and FOXP3 RNA levels were up-regulated in PBC case patients (1.75- and 1.64-fold, respectively). Conclusions: This work represents the first comprehensive study, to our knowledge, of the chrX contribution to the genetics of an autoimmune liver disease and shows a novel PBC-related genome-wide significant locus.
AB - Background & Aims: Genome-wide association studies in primary biliary cholangitis (PBC) have failed to find X chromosome (chrX) variants associated with the disease. Here, we specifically explore the chrX contribution to PBC, a sexually dimorphic complex autoimmune disease. Methods: We performed a chrX-wide association study, including genotype data from 5 genome-wide association studies (from Italy, United Kingdom, Canada, China, and Japan; 5244 case patients and 11,875 control individuals). Results: Single-marker association analyses found approximately 100 loci displaying P < 5 × 10–4, with the most significant being a signal within the OTUD5 gene (rs3027490; P = 4.80 × 10–6; odds ratio [OR], 1.39; 95% confidence interval [CI], 1.028–1.88; Japanese cohort). Although the transethnic meta-analysis evidenced only a suggestive signal (rs2239452, mapping within the PIM2 gene; OR, 1.17; 95% CI, 1.09–1.26; P = 9.93 × 10–8), the population-specific meta-analysis showed a genome-wide significant locus in East Asian individuals pointing to the same region (rs7059064, mapping within the GRIPAP1 gene; P = 6.2 × 10–9; OR, 1.33; 95% CI, 1.21–1.46). Indeed, rs7059064 tags a unique linkage disequilibrium block including 7 genes: TIMM17B, PQBP1, PIM2, SLC35A2, OTUD5, KCND1, and GRIPAP1, as well as a superenhancer (GH0XJ048933 within OTUD5) targeting all these genes. GH0XJ048933 is also predicted to target FOXP3, the main T-regulatory cell lineage specification factor. Consistently, OTUD5 and FOXP3 RNA levels were up-regulated in PBC case patients (1.75- and 1.64-fold, respectively). Conclusions: This work represents the first comprehensive study, to our knowledge, of the chrX contribution to the genetics of an autoimmune liver disease and shows a novel PBC-related genome-wide significant locus.
KW - Meta-analysis
KW - Superenhancer
KW - X-Wide Association Study
UR - http://www.scopus.com/inward/record.url?scp=85107319095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107319095&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2021.02.061
DO - 10.1053/j.gastro.2021.02.061
M3 - Article
C2 - 33675743
AN - SCOPUS:85107319095
SN - 0016-5085
VL - 160
SP - 2483-2495.e26
JO - Gastroenterology
JF - Gastroenterology
IS - 7
ER -